[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351835-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351835-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","increased-vulnerability-of-colorectal-cancer-models-with-high-alkylation-damage-to-nthl1-inactivation","Increased vulnerability of colorectal cancer models with high alkylation damage to NTHL1 inactivation","","The study investigates how alkylation DNA damage influences colorectal cancer sensitivity to NTHL1 loss. The alkylating mutational signature closely matches patterns seen with NTHL1 inactivation within Base Excision Repair. Colorectal cancer cells and patient-derived organoids with high alkylation damage plus NTHL1 inactivation show reduced viability and proliferation, linked to elevated DNA damage responses and G2/S cell-cycle arrest. CHK1 inhibition further increases apoptosis in this tumor subset.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/increased-vulnerability-of-colorectal-cancer-models-with-high-alkylation-damage-to-nthl1-inactivation/351835/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/increased-vulnerability-of-colorectal-cancer-models-with-high-alkylation-damage-to-nthl1-inactivation/351835.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does high alkylation damage increase colorectal cancer vulnerability to NTHL1 inactivation?","Question",{"text":63,"@type":64},"The work links high alkylation damage to defective processing when NTHL1 is inactivated, producing heightened DNA damage repair signaling and G2/S cell-cycle arrest, which reduces viability and proliferation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the impact of CHK1 inhibition in colorectal cancers with high alkylation damage and NTHL1 inactivation?",{"text":68,"@type":64},"In this tumor subset, CHK1 inhibition leads to enhanced apoptosis, strengthening the anti-cancer effect when combined with NTHL1 inactivation and alkylation damage.",{"name":70,"@type":61,"acceptedAnswer":71},"Do colorectal cancers with low alkylation also respond to NTHL1 deletion and CHK1 inhibition after alkylating-agent treatment?",{"text":72,"@type":64},"Yes. After alkylating-agent treatment, low-alkyl colorectal cancers show vulnerability to NTHL1 deletion and increased sensitivity to CHK1 inhibition.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351835,1790914743,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIncreased vulnerability of colorectal cancer models with high alkylation damage to NTHL1 inactivation  \nHyeoncheol Kim1,2, Jules Cazaubiel1,2, Tung-Lin Chiang1,3, Dimitrios Stylianakis1,  \nSamantha Fitzgerald1,2, Pushpamali De Silva1,2, Carino Gurjao1,2 & Marios Giannakis1,2􀀍  \nThe mutational signature of alkylating damage is highly similar to the one associated with inactivation of NTHL1, a gene involved in Base Excision Repair. We hypothesized that colorectal cancers (CRCs) with high alkylation damage, could be selectively vulnerable to NTHL1 deletion. We found that CRC cells and patient-derived organoids with high alkylation damage, coupled with NTHL1 inactivation, are less viable and exhibit reduced cellular proliferation due to heightened DNA damage repair response and G2/S cell cycle arrest. CHK1 inhibition in this subset of tumors led to enhanced apoptosis. Notably, CRCs with low alkylation, following treatment with alkylating agents, also exhibit vulnerability to NTHL1 deletion and increased sensitivity toCHK1 inhibition. Our study thus demonstrates that the combination of alkylation damage and NTHL1 inactivation leads to synthetic sickness in CRC, further sensitization to CHK1 inhibition, and reveals potential therapeutic vulnerabilities in CRC.  \nKeywords DNA alkylation, Base excision repair (BER), DNA damage, Colorectal cancer , Synthetic lethality  \nColorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality and its incidence has increased dramatically in the last few decades among younger individuals1. One key CRC risk factor is dietary red meat, which has been classified as a carcinogen2–4. Red meat heme iron induces the release of reactive oxygen species (ROS), which in turn can induce DNA damage, thereby increasing the risk of cancer development5–7. In addition to ROS, DNA alkylation induced by red meat-associated N-nitroso compounds (NOCs), which are metabolic products of blood heme iron or meat nitrites/nitrates8,9, is associated with increased mutagenesisin CRC cells3, 10. Through whole-exome sequencing of CRCs from prospective cohort studies with matched lifestyle data, we have previously described a CRC alkylating mutational signature (c-alkyl) associated with high pre-diagnosis intake of red meat and oncogenic mutations KRAS p.G12D, KRAS p.G13D, and PIK3CAp.E545K3, 11–13.  \nThere are several major pathways for the repair of DNA alkylation damage, including the methylguanine methyltransferase (MGMT) pathway and the Base excision repair (BER) pathway14–16. The NTHL1 gene plays a crucial role in BER; it encodes a DNA glycosylase that specifically targets oxidized pyrimidine residues in DNA and possesses apurinic/apyrimidinic lyase activity17, 18. NTHL1 tumor syndrome, also known as NTHL1-associated polyposis, is caused by biallelic inactivating variants in NTHL119,20. Inactivating mutations in NTHL1 result in BER deficiency and the SBS30 DNA mutational signature19,21. In previous work, we found that SBS30 shows a high similarity and overlaps with the c-alkyl mutational signature, which is found in patients with sporadic CRC3. This is likely due to how alkylating damage is processed, with many small alkyl adducts repaired by BER, while O⁶-alkylguanine lesions are directly reversed by MGMT22,23.  \nWe thus hypothesized that NTHL1 could be a selective vulnerability in CRCs with high alkylation damage. Using genomically-edited CRC cells and patient-derived organoids, we found that high-c-alkyl CRCs with NTHL1 knockout (KO) showed decreased proliferation, increased DNA damage and cell cycle arrest compared to low c-alkyl CRCs. The accumulation of DNA damage in high c-alkyl models with NTHL1 KO resulted in synthetic lethality with CHK inhibitors. Our data demonstrates synergistic anti-cancer activity between NTHL1 inactivation and high DNA alkylation in CRC, which is further augmented with CHK1 inhibition.  \n1Depa","cbCaiatEYzmhZiH7","https://ap.wps.com/l/cbCaiatEYzmhZiH7","pdf",10093885,15,"English","# Results\n## NTHL1 knockout differentially affects colorectal cancer cell viability depending on alkylation status","[{\"question\":\"Why does high alkylation damage increase colorectal cancer vulnerability to NTHL1 inactivation?\",\"answer\":\"The work links high alkylation damage to defective processing when NTHL1 is inactivated, producing heightened DNA damage repair signaling and G2/S cell-cycle arrest, which reduces viability and proliferation.\"},{\"question\":\"What is the impact of CHK1 inhibition in colorectal cancers with high alkylation damage and NTHL1 inactivation?\",\"answer\":\"In this tumor subset, CHK1 inhibition leads to enhanced apoptosis, strengthening the anti-cancer effect when combined with NTHL1 inactivation and alkylation damage.\"},{\"question\":\"Do colorectal cancers with low alkylation also respond to NTHL1 deletion and CHK1 inhibition after alkylating-agent treatment?\",\"answer\":\"Yes. After alkylating-agent treatment, low-alkyl colorectal cancers show vulnerability to NTHL1 deletion and increased sensitivity to CHK1 inhibition.\"}]","Increased vulnerability of colorectal cancer models with high alkylation damage to NTHL1 inactivation | PDF",1790096256,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6665b1caeedca49596dde0de915f51d8.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3218b81f82889f35c7f700fb7e61b264.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1e54480f51a4013b986391635f4bc03.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d28f6ac8d8b60e79371e1ecbab0c21.webp",980,1287]